At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Jul 2, 2026 at 17:00 ET
COO/CBO Joshua Hexter and CFO Avraham Gabay collectively sold $942K in open-market shares on July 1, 2026, representing ~0.5% of Oramed's $189M market cap. The sales are moderate in size and involve two senior officers, but insider selling is a weak directional signal per academic literature, especially without evidence of 10b5-1 plans or a clear blackout context.
- Two C-suite insiders (COO/CBO and CFO) sold shares on July 1, 2026
- Total open-market sales: $942,000 at ~$4.46-$4.51 per share
- Sales represent ~0.5% of Oramed's $189M market cap
- Hexter also exercised derivatives on July 2 (non-cash events)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access